Anticholinergics for neuroleptic-induced acute akathisia

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Rathbone, John ^a   Soares Weiser, Karla ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Enhance Reviews   (Israel)

Author keywords

Akathisia, drug induced *drug therapy ; Antipsychotic agents *adverse effects ; Cholinergic antagonists *therapeutic use ; Humans

Indexed keywords

BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPERIDEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXETIMIDE; NEUROLEPTIC AGENT; ORPHENADRINE; PROCYCLIDINE; RITANSERIN; SCOPOLAMINE; TRIHEXYPHENIDYL;

AKATHISIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INDUCED DISEASE; DYSKINESIA; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHIZOPHRENIA;

EID: 77950168457     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003727.pub3     Document Type: Review

References (37)

1. Adler 1987 {published data only} Adler LA, Reiter S, Corwin J, Hemdal P, Angrist B, Rotrosen J. Differential effects of propranolol and benztropine in patients with neuroleptic-induced akathisia. Psychopharmacology Bulletin 1987; 23(3):519-21.
2. Adler 1988 {published data only} Adler LA, Reiter S, Corwin J, Hemdal P, Angrist B, Rotrosen J. Neuroleptic-induced akathisia: propranolol versus benztropine. Biological Psychiatry 1988;23:209-14.
3. Adler 1993 {published data only} * Adler LA, Peselow E, Rosenthal M, Angrist B. A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis. Psychopharmacology Bulletin 1993;29(2):283-6.
4. Friss 1983 {published data only} Friss T, Christensen R, Gerlach J. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia: a double-blind, placebo, cross-over study with placebo. Acta Psychiatrica Scandinavica 1983;67:178-87.
5. Gagrat 1978 {published data only} Gagrat D, Hamilton J, Belmaker RH. Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia. American Journal of Psychiatry 1978;135(10):1232-3.
6. Hermesh 1988 {published data only} Hermesh H, Molcho A, Munitz H. Successful propranolol therapy for neuroleptic-induced akathisia resistant to anticholinergic and benzodiazepine drugs. Clinical Neuropharmacology 1988;11(4): 369-72.
7. Hirose 2000 {published data only} Hirose S, Ashby CR. Intravenous biperiden in akathisia: an open pilot study. International Journal of Psychiatry in Medicine 2000;30 (2):185-94.
8. Horiguchi 1992 {published data only} Horiguchi J, Nishimatsu O. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study. Japanese Journal of Psychiatry and Neurology 1992;46(3):733-9.
9. Neu 1972 {published data only} Neu C, Demascio A, Dermigian E. Antiparkinsonian medication in the treatment of extrapyramidal side-effects: single or multiple daily doses?. Current Therapeutic Research 1972;14(5):246-51.
10. Sachdev 1993 {published data only} * Sachdev P, Loneragan C. Intravenous benztropine and propranolol challenges in acute neuroleptic-induced akathisia. Clinical Neuropharmacology 1993;16(4):324-31.
11. Sachdev P, Loneragan C. Intravenous benztropine and propranolol challenges in tardive akathisia. Psychopharmacology 1993;113: 119-22.
12. Zeng 1995 {published data only} Zeng ZX, Jing LR, Liu L, Meng QL, Zhang YD. Dexetimide and benzhexolum in the treatment of drug-induced akathisia: a doubleblind controlled trial. Chinese Journal of Pharmacoepidemiology 1995;4(2):72-3.
13. Altman 1996 Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
14. Armitage 1991 Armitage P. Should we cross-off the cross-over?. British Journal of Clinical Pharmacology 1991;32:1-2.
15. Ayd 1961 Ayd FJ. A survey of drug-induced extrapyramidal reactions. JAMA 1961;175:1054-60.
16. Barnes 1992 Barnes TRE. Neuromuscular effects of neuroleptics: akathisia. In: Lieberman J, Kane JM editor(s). Adverse effects of psychotropic drugs. New York: Guilford Publications, 1992:201-17.
17. Barnes 1993 Barnes TRE, Edwards JG. The side effects of antipsychotic drugs. I. CNS and neuromuscular effects. Antipsychotic drugs and their side effects. London: Harcourt Brace & Company, 1993.
18. Bland 1997 Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
19. Braude 1983 Braude WM, Barnes TRE, Gore S. Clinical characteristics of akathisia: a systematic investigation of acute psychiatric inpatient admissions. British Journal of Psychiatry 1983;143:139- 50.
20. Divine 1992 Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9.
21. Donner 2002 Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-80.
22. Egger 1997 Egger M, Davey-Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315: 629-34.
23. Farde 1992 Farde L, Norstrom AL, Halldin C. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clinical Journal of Neuropharmacology 1992;15 Supple 1 Pt - A: 468A-469A.
24. Grebb 1995 Grebb JA. Medication induced movement disorders. In: Kaplan HI, Sadock BJ editor(s). Comprehensive textbook of psychiatry. New York: Williams & Wilkins, 1995.
25. Gulliford 1999 Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83; 876-83.
26. Halstead 1994 Halstead SM, Barnes TR, Speller JC. Akathisia: prevalence and associated dysphoria in an inpatient population with chronic schizophrenia. British Journal of Psychiatry 1994;164(2):177-83.
27. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
28. Higgins 2005 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: Higgins JPT, Green S editor(s). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd., 2005.
29. Jadad 1996 Jadad A, Moore A, Carrol D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
30. Marder 1991 Marder SR, Midha KK, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, et al.Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. British Journal of Clinical Psychiatry 1991;158:658-65.
31. Marshall 2000 Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
32. Moher 2001 Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91.
33. Schooler 1993 Schooler NR, Keith SJ. The clinical research base for the treatment of schizophrenia. Psychopharmacology Bulletin 1993;29:431-46.
34. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273: 408-12.
35. Ukoumunne 1999 Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75.
36. Lima 2002 Lima AR,Weiser KV, Bacaltchuk J, Barnes TR. Anticholinergics for neuroleptic-induced acute akathisia. Cochrane Database Systematic Reviews 2002, Issue 3.[Art. No.: CD003727. DOI: 10.1002/ 14651858.CD003727.pub3]
37. Lima 2004 Lima AR,Weiser KV, Bacaltchuk J, Barnes TR. Anticholinergics for neuroleptic-induced acute akathisia. Cochrane Database Systematic Reviews 2004, Issue 1.[Art. No.: CD003727. DOI: 10.1002/ 14651858.CD003727.pub3]